Patient Guide: Clinical Outcomes of Prolensa (Bromfenac Ophthalmic Solution) 0.07% QD vs Ilevro (Nepafenac Ophthalmic Suspension) 0.3% QD With Extra (Pulse) Dose on Day of Surgery for Treatment of Ocular Inflammation Associated With Cataract Surgery in a Randomized, Single Masked Clinical Trial

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03886779
Status: ANNOUNCED
Condition: Ocular Inflammation, Cataract Surgery
Phase: NA

Loading interactive enrollment tools...

The full interactive experience will load momentarily